세계의 당뇨병 줄기세포 치료 시장 보고서(2025년)

Diabetes stem cell therapy refers to a medical approach that uses stem cells to treat or manage diabetes by regenerating, replacing, or repairing damaged pancreatic cells, particularly insulin-producing beta cells. It is widely used in clinical research and regenerative medicine to improve blood glucose control, reduce diabetes-related complications, and support potential long-term disease management.

The primary types of therapies in the diabetes stem cell therapy market include preclinical and clinical phase 1 and 2 therapies. Preclinical therapies refer to treatments in the experimental stage, typically tested in laboratory and animal models to assess safety, efficacy, and potential therapeutic benefits before progressing to human clinical trials. These therapies include autologous, allogeneic, induced pluripotent, mesenchymal, and hematopoietic stem cell treatments, delivered through methods such as intravenous injection, intramuscular injection, intra-pancreatic injection, and local tissue delivery. They are applied in areas such as type 1 diabetes treatment, type 2 diabetes management, diabetic complication treatment, and islet cell transplantation, and are primarily utilized by hospitals, research institutes, diabetes clinics, and pharmaceutical companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The diabetes stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides diabetes stem cell therapy market statistics, including the diabetes stem cell therapy industry global market size, regional shares, competitors with the diabetes stem cell therapy market share, detailed diabetes stem cell therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes stem cell therapy industry. This diabetes stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes stem cell therapy market size has grown rapidly in recent years. It will grow from $2.68 billion in 2024 to $3.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be linked to the growing prevalence of diabetes, rising healthcare expenditure, increasing awareness about regenerative therapies, growing government support for stem cell research, and increasing availability of clinical trial infrastructure.

The diabetes stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be driven by increasing demand for personalized medicine, a rising number of stem cell therapy clinics, growing investment in biotechnology, increasing favorable reimbursement policies, and growing adoption of advanced therapeutic solutions. Major trends in the forecast period include technological advancements in stem cell engineering, innovations in cell delivery systems, developments in regenerative medicine protocols, integration of artificial intelligence in therapy design, and collaborations between biotech companies and research institutes.

The growing need for novel treatments is expected to drive the growth of the diabetes stem cell therapy market in the coming years. Novel treatments are therapies that use new mechanisms, targets, or approaches not previously available for disease management. This demand is rising due to the increasing prevalence of complex and chronic diseases, as conventional therapies often fail to provide effective or long-term solutions. Diabetes stem cell therapy addresses this need by offering regenerative solutions that can restore pancreatic function, reduce insulin dependence, and potentially provide a long-term cure for diabetes. For instance, in January 2025, the National Center for Biotechnology Information (NCBI) reported that 1,035 new drugs were approved, of which 337 were novel drugs, including 81 first-in-class therapies, accounting for 24% of all novel approvals. Consequently, the growing need for novel treatments is fueling the diabetes stem cell therapy market.

Companies in the diabetes stem cell therapy market are focusing on advances in biotechnology, stem cell research, and regenerative medicine to provide cellular therapies that restore insulin production and improve glycemic control in patients with type 1 diabetes. These approaches involve the use of living cells, tissues, and molecular techniques to repair, replace, or regenerate damaged organs or cells, offering advanced treatment options for chronic diseases. In June 2023, CellTrans Inc., a US-based biotechnology firm, received FDA approval for Lantidra, the first allogeneic pancreatic islet cellular therapy made from deceased donor pancreatic cells for adults with type 1 diabetes experiencing recurrent severe hypoglycemia. Administered via a single infusion into the hepatic portal vein, the transplanted islet beta cells secrete insulin, allowing some patients to achieve insulin independence for one year or more, with cases extending up to five years, significantly improving disease management, glycemic control, and quality of life.

In June 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Sigilon Therapeutics Inc. for $309.6 million. Through this acquisition, Eli Lilly aims to strengthen its capabilities in encapsulated cell-therapy solutions for type 1 diabetes by integrating Sigilon's shielded-cell technology into its portfolio. Sigilon Therapeutics Inc. is a US-based biopharmaceutical company developing stem cell-based therapies for type 1 diabetes.

Major companies operating in the diabetes stem cell therapy market are Bristol-Myers Squibb Company, Gilead Sciences Inc., Mesoblast Limited, Evotec SE, Swiss Medica Stem Cells SA, Aspect Biosystems Ltd., Celltex Therapeutics Corporation, Adocia SA, Seraxis Inc., BrainStorm Cell Therapeutics Inc., Sernova Corporation, Betalin Therapeutics Ltd., NextCell Pharma AB, PharmaCyte Biotech Inc., Global Institute for Stem Cell Therapy and Research, Throne Biotechnologies Inc., Orgenesis Inc., Holostem Terapie Avanzate S.r.l., Anterogen Co. Ltd., Juventa Regenerative Medicine Inc.

North America was the largest region in the diabetes stem cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes stem cell therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes stem cell therapy market consists of revenues earned by entities by providing services such as stem cell transplantation services, quality control testing, logistics and cryopreservation services, and patient monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes stem cell therapy market also includes sales of bioreactors, syringes, cell therapy kits, diagnostic kits, and laboratory consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Stem Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes stem cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes stem cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Preclinical; Clinical Phase 1,2
• 2) By Therapy Type: Autologous Stem Cell Therapy; Allogeneic Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Hematopoietic Stem Cell Therapy
• 3) By Delivery Method: Intravenous Injection; Intramuscular Injection; Intra-Pancreatic Injection; Local Tissue Delivery
• 4) By Application: Type 1 Diabetes Treatment; Type 2 Diabetes Management; Diabetic Complications Treatment; Islet Cell Transplantation
• 5) By End-User: Hospitals; Research Institutes; Diabetes Clinics; Pharmaceutical Companies
• Subsegments:
• 1) By Preclinical: Embryonic Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Hematopoietic Stem Cell Therapy
• 2) By Clinical Phase 1 And 2: Autologous Stem Cell Therapy; Allogeneic Stem Cell Therapy; Pancreatic Islet Cell Therapy; Encapsulated Cell Therapy; Beta Cell Replacement Therapy; Immune Modulation Therapy; Gene-Modified Stem Cell Therapy; Combination Stem Cell Therapy
• Companies Mentioned: Bristol-Myers Squibb Company; Gilead Sciences Inc.; Mesoblast Limited; Evotec SE; Swiss Medica Stem Cells SA; Aspect Biosystems Ltd.; Celltex Therapeutics Corporation; Adocia SA; Seraxis Inc.; BrainStorm Cell Therapeutics Inc.; Sernova Corporation; Betalin Therapeutics Ltd.; NextCell Pharma AB; PharmaCyte Biotech Inc.; Global Institute for Stem Cell Therapy and Research; Throne Biotechnologies Inc.; Orgenesis Inc.; Holostem Terapie Avanzate S.r.l.; Anterogen Co. Ltd.; Juventa Regenerative Medicine Inc.
• Countries:

Table of Contents

1. Executive Summary

2. Diabetes Stem Cell Therapy Market Characteristics

3. Diabetes Stem Cell Therapy Market Trends And Strategies

4. Diabetes Stem Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diabetes Stem Cell Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diabetes Stem Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diabetes Stem Cell Therapy Market Growth Rate Analysis
• 5.4. Global Diabetes Stem Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diabetes Stem Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diabetes Stem Cell Therapy Total Addressable Market (TAM)

6. Diabetes Stem Cell Therapy Market Segmentation

• 6.1. Global Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical
• Clinical Phase 1,2
• 6.2. Global Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy
• Induced Pluripotent Stem Cell (iPSC) Therapy
• Mesenchymal Stem Cell (MSC) Therapy
• Hematopoietic Stem Cell Therapy
• 6.3. Global Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Injection
• Intramuscular Injection
• Intra-Pancreatic Injection
• Local Tissue Delivery
• 6.4. Global Diabetes Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type 1 Diabetes Treatment
• Type 2 Diabetes Management
• Diabetic Complications Treatment
• Islet Cell Transplantation
• 6.5. Global Diabetes Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Diabetes Clinics
• Pharmaceutical Companies
• 6.6. Global Diabetes Stem Cell Therapy Market, Sub-Segmentation Of Preclinical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embryonic Stem Cell Therapy
• Induced Pluripotent Stem Cell Therapy
• Mesenchymal Stem Cell Therapy
• Hematopoietic Stem Cell Therapy
• 6.7. Global Diabetes Stem Cell Therapy Market, Sub-Segmentation Of Clinical Phase 1 And 2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Stem Cell Therapy
• Allogeneic Stem Cell Therapy
• Pancreatic Islet Cell Therapy
• Encapsulated Cell Therapy
• Beta Cell Replacement Therapy
• Immune Modulation Therapy
• Gene-Modified Stem Cell Therapy
• Combination Stem Cell Therapy

7. Diabetes Stem Cell Therapy Market Regional And Country Analysis

• 7.1. Global Diabetes Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diabetes Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Stem Cell Therapy Market

• 8.1. Asia-Pacific Diabetes Stem Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Stem Cell Therapy Market

• 9.1. China Diabetes Stem Cell Therapy Market Overview
• 9.2. China Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Stem Cell Therapy Market

• 10.1. India Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Stem Cell Therapy Market

• 11.1. Japan Diabetes Stem Cell Therapy Market Overview
• 11.2. Japan Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Stem Cell Therapy Market

• 12.1. Australia Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Stem Cell Therapy Market

• 13.1. Indonesia Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Stem Cell Therapy Market

• 14.1. South Korea Diabetes Stem Cell Therapy Market Overview
• 14.2. South Korea Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Stem Cell Therapy Market

• 15.1. Western Europe Diabetes Stem Cell Therapy Market Overview
• 15.2. Western Europe Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Stem Cell Therapy Market

• 16.1. UK Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Stem Cell Therapy Market

• 17.1. Germany Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Stem Cell Therapy Market

• 18.1. France Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Stem Cell Therapy Market

• 19.1. Italy Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Stem Cell Therapy Market

• 20.1. Spain Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Stem Cell Therapy Market

• 21.1. Eastern Europe Diabetes Stem Cell Therapy Market Overview
• 21.2. Eastern Europe Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Stem Cell Therapy Market

• 22.1. Russia Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Stem Cell Therapy Market

• 23.1. North America Diabetes Stem Cell Therapy Market Overview
• 23.2. North America Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Stem Cell Therapy Market

• 24.1. USA Diabetes Stem Cell Therapy Market Overview
• 24.2. USA Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Stem Cell Therapy Market

• 25.1. Canada Diabetes Stem Cell Therapy Market Overview
• 25.2. Canada Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Stem Cell Therapy Market

• 26.1. South America Diabetes Stem Cell Therapy Market Overview
• 26.2. South America Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Stem Cell Therapy Market

• 27.1. Brazil Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Stem Cell Therapy Market

• 28.1. Middle East Diabetes Stem Cell Therapy Market Overview
• 28.2. Middle East Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Stem Cell Therapy Market

• 29.1. Africa Diabetes Stem Cell Therapy Market Overview
• 29.2. Africa Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Stem Cell Therapy Market Competitive Landscape And Company Profiles

• 30.1. Diabetes Stem Cell Therapy Market Competitive Landscape
• 30.2. Diabetes Stem Cell Therapy Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Mesoblast Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Evotec SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Swiss Medica Stem Cells SA Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Stem Cell Therapy Market Other Major And Innovative Companies

• 31.1. Aspect Biosystems Ltd.
• 31.2. Celltex Therapeutics Corporation
• 31.3. Adocia SA
• 31.4. Seraxis Inc.
• 31.5. BrainStorm Cell Therapeutics Inc.
• 31.6. Sernova Corporation
• 31.7. Betalin Therapeutics Ltd.
• 31.8. NextCell Pharma AB
• 31.9. PharmaCyte Biotech Inc.
• 31.10. Global Institute for Stem Cell Therapy and Research
• 31.11. Throne Biotechnologies Inc.
• 31.12. Orgenesis Inc.
• 31.13. Holostem Terapie Avanzate S.r.l.
• 31.14. Anterogen Co. Ltd.
• 31.15. Juventa Regenerative Medicine Inc.

32. Global Diabetes Stem Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Stem Cell Therapy Market

34. Recent Developments In The Diabetes Stem Cell Therapy Market

35. Diabetes Stem Cell Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Diabetes Stem Cell Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diabetes Stem Cell Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diabetes Stem Cell Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer